Sunday symposia featuring facial dermatoses, women’s health, and mucosal disease

Tomorrow may be the last day of Summer Meeting, but that doesn’t mean you should skip out early. On the contrary, we’ve saved some of the best for last, including a brand new session on mucosal disease. All three of the following symposia take place from 9 a.m. to noon on Sunday.

Acne, rosacea, and other facial dermatoses are treated by dermatologists on a daily basis. Joshua Zeichner, MD, and James Q. Del Rosso, DO, will co-direct the session “Acne, Rosacea, and Other Common Dermatoses: Can We Do Better?” Advances in clinician understanding of their pathophysiology translate to improvements in treatment algorithms and patient outcomes. Education and patient-tailored approaches also are needed to optimally manage these dermatoses. This session will take place in Grand Ballroom EF.

“Women’s Health Therapeutic Hotline,” a practical course filled with therapeutic pearls and counseling tips, highlights issues in women’s health and hormonal therapy in dermatology. Jenny Eileen Murase, MD, will direct the symposium, which will review new approaches to drug safety in pregnancy, as well as management of psoriasis, pemphigus, cutaneous lupus, and eczematous dermatitis. The appropriate use of hormonal therapy in dermatology also will be addressed, including how to prescribe oral contraceptives safely and whether finasteride and spironolactone improve female pattern androgenetic alopecia. Finally, the appropriate medical management of mastitis in breastfeeding mothers and medication safety issues in lactation will be covered. This session will take place in Grand Ballroom B.

Mucosal diseases are relatively rare and are challenging to the patients and especially to dermatologists and clinicians who care for these patients. “Mucosal Session,” co-directed by Ginat W. Mirowski, MD, DMD, and Rochelle R. Torgerson, MD, PhD, seeks to raise awareness of second-, third-, and fourth-line drugs that may be available to care for these complex patients. It is important to also make clinicians aware of the extensive non-dermatologic involvement so as to limit the severe morbidity these patients suffer as a result of this practice gap. This session will take place in Grand Ballroom A.

Return to index